PV Bulletin

GE HealthCare Infant Resuscitation System Air-Oxygen Blender Issue

FDA issued an early alert regarding a potentially high-risk issue with GE HealthCare Infant Resuscitation Systems where the air-oxygen blender knob shaft can loosen, affecting delivered oxygen concentration.

PV Impact Brief

Urgency: HighConfidence: high

What changed

FDA issued an Early Alert notifying the public of a potentially high-risk device issue with GE HealthCare Infant Resuscitation Systems, recommending affected devices be corrected prior to continued use.

Why it matters

The issue could lead to hypoxia or hyperoxia in infant patients if the device delivers incorrect oxygen concentration.

Action needed

Identify and remove affected devices from use until corrected; if use is necessary, follow additional precautions provided in the GE HealthCare customer letter.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

as needed until resolved

Regulatory action details

Action type
Early Alert
Publication date
2026-06-05
Safety issue
The FDA issued an early alert regarding an issue with the Infant Resuscitation System from GE HealthCare.

Affected products

  • Infant Resuscitation System
    GE HealthCare

PV internal implications

Follow the instructions in the alert.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 5, 2026

Full briefing

Practical implication

Identify and remove affected devices from use until corrected; if use is necessary, follow additional precautions provided in the GE HealthCare customer letter.

FDA issued an early alert on June 5, 2026, concerning GE HealthCare Infant Resuscitation Systems and Warmers with M1091607-R blender. The knob shaft may loosen, causing oxygen concentration mismatch and potential hypoxia or hyperoxia. No serious injuries or deaths reported as of May 20, 2026.

What changed: FDA issued an Early Alert notifying the public of a potentially high-risk device issue with GE HealthCare Infant Resuscitation Systems, recommending affected devices be corrected prior to continued use.

Why it matters: The issue could lead to hypoxia or hyperoxia in infant patients if the device delivers incorrect oxygen concentration.

Practical implication: Identify and remove affected devices from use until corrected; if use is necessary, follow additional precautions provided in the GE HealthCare customer letter.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward